EU abandons draft price transparency directive
This article was originally published in Scrip
Executive Summary
The European Commission has abandoned efforts to reach agreement on a revised version of the EU's price transparency directive, and has recommended that the draft legislation should no longer be pursued.
You may also be interested in...
EU Price Transparency Directive Review Must Lead To ‘Concrete Outcomes’
Industry figures hope that the European Commission’s review of the EU’s directive on the transparency of pricing and reimbursement processes will produce tangible outcomes that help get medicines to patients more quickly.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.